Lakefront Biotherapeutics NV annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Lakefront Biotherapeutics NV Capital Expenditures (CapEx) Growth & History (LKFT)
Lakefront Biotherapeutics NV's capital expenditures (capex) was €13.7M for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €13.7M | −€3.0M | −18.04% |
| 2024 | 2024-12-31 | €16.7M | −€2.0M | −10.62% |
| 2023 | 2023-12-31 | €18.7M | −€8.7M | −31.70% |
| 2022 | 2022-12-31 | €27.4M | −€26.8M | −49.47% |
| 2021 | 2021-12-31 | €54.2M | €11.7M | +27.48% |
| 2020 | 2020-12-31 | €42.5M | €20.1M | +89.96% |
| 2019 | 2019-12-31 | €22.4M | €12.0M | +115.41% |
| 2018 | 2018-12-31 | €10.4M | €5.1M | +95.63% |
| 2017 | 2017-12-31 | €5.3M | €854,000 | +19.16% |
| 2016 | 2016-12-31 | €4.5M | −€1.6M | −26.92% |
| 2015 | 2015-12-31 | €6.1M | — | — |
Lakefront Biotherapeutics NV quarterly capital expenditures (capex)
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €29,000 | −€4.1M | −99.30% |
| Q1 2026 | 2026-03-31 | €123,000 | −€5.1M | −97.66% |
| Q4 2025 | 2025-12-31 | €1.6M | — | — |
| Q3 2025 | 2025-09-30 | €2.9M | — | — |
| Q2 2025 | 2025-06-30 | €4.2M | — | — |
| Q1 2025 | 2025-03-31 | €5.3M | — | — |
Lakefront Biotherapeutics NV capital expenditures (capex) trends
Over the last five fiscal years, Lakefront Biotherapeutics NV's capital expenditures (capex) decreased from €42.5M to €13.7M, a change of −€28.8M. The latest reported quarter, Q2 2026, shows €29,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV source filings ↗